Cargando…
Circulating miRNAs as biomarkers in diffuse large B-cell lymphoma: a systematic review
Diffuse large B-cell lymphoma (DLBCL) is an aggressive and heterogeneous malignancy, with highly variable outcomes among patients. Although classification and prognostic tools have been developed, standard therapy still fails in 30-40% of patients. Hence, identification of novel biomarkers is needed...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978269/ https://www.ncbi.nlm.nih.gov/pubmed/29854319 http://dx.doi.org/10.18632/oncotarget.25230 |